2023-24 Annual report
2023-24 Executive team
April 1, 2023 – March 31, 2024

Dr. Craig Earle
Chief Executive Officer

Erika Nicholson
Vice President, Cancer Systems and Innovation

Andrea Reed
Vice President, Strategic Partnerships

Shelley Tapp
Vice President, Finance and Corporate Services (joined January 2024)

David Lynch
Vice President, Finance and Corporate Services (retired December 2023)

Rami Rahal
Vice President, Cancer Systems, Performance and Innovation (resigned June 2023)